Serhii Chornyi

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Correction: Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation.

Correction: Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation.

Journal: Acta neuropathologica

Published: September 04, 2026

Sex-dependent bioactive lipid mediator profiles in multiple sclerosis.

Sex-dependent bioactive lipid mediator profiles in multiple sclerosis.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: March 18, 2026

Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation.

Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation.

Journal: Acta neuropathologica

Published: January 13, 2026

Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation.

Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation.

Journal: Acta neuropathologica

Published: January 13, 2026

Distinct CSF lipidomic profiles are associated with five proteomic subtypes in patients with Alzheimer's disease.

Distinct CSF lipidomic profiles are associated with five proteomic subtypes in patients with Alzheimer's disease.

Journal: Molecular neurodegeneration advances

Published: July 17, 2025

Fatty acid binding protein 2 (FATP2/SLC27A2) blockade with Lipofermata elicits dual effects on inflammatory responses in human monocytes and macrophages.

Fatty acid binding protein 2 (FATP2/SLC27A2) blockade with Lipofermata elicits dual effects on inflammatory responses in human monocytes and macrophages.

Journal: Immunology letters

Published: May 31, 2025

Single-cell spatial transcriptomic profiling defines a pathogenic inflammatory niche in chronic active multiple sclerosis lesions.

Single-cell spatial transcriptomic profiling defines a pathogenic inflammatory niche in chronic active multiple sclerosis lesions.

Journal: Immunity

Published: April 16, 2025

Spatial mapping of the AA-PGE2-EP axis in multiple sclerosis lesions.

Spatial mapping of the AA-PGE2-EP axis in multiple sclerosis lesions.

Journal: Acta neuropathologica

Published: October 18, 2024

Docosahexaenoic acid prevents peroxisomal and mitochondrial protein loss in a murine hepatic organoid model of severe malnutrition.

Docosahexaenoic acid prevents peroxisomal and mitochondrial protein loss in a murine hepatic organoid model of severe malnutrition.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: June 05, 2024

Studying the topology of peroxisomal acyl-CoA synthetases using self-assembling split sfGFP.

Studying the topology of peroxisomal acyl-CoA synthetases using self-assembling split sfGFP.

Journal: Histochemistry and cell biology

Published: November 24, 2023

The solute carrier SLC25A17 sustains peroxisomal redox homeostasis in diverse mammalian cell lines.

The solute carrier SLC25A17 sustains peroxisomal redox homeostasis in diverse mammalian cell lines.

Journal: Free radical biology & medicine

Published: August 30, 2023

Peroxisomal NAD(H) Homeostasis in the Yeast Debaryomyces hansenii Depends on Two Redox Shuttles and the NAD+ Carrier, Pmp47.

Peroxisomal NAD(H) Homeostasis in the Yeast Debaryomyces hansenii Depends on Two Redox Shuttles and the NAD+ Carrier, Pmp47.

Journal: Biomolecules

Published: July 20, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026